Posted on 6/25/20
Moderna and Catalent Announce Collaboration for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate
CAMBRIDGE, Mass. & SOMERSET, N.J.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation . . .
Posted on 6/25/20
CVS Health: Strong First Quarter Means It's Worth More Than 9x PE
SummaryThe first quarter of 2020 shows CVS huge potential going forward.COVID-19 shows a demand for more health care services is on the horizon.CVS continues to grow . . .
Posted on 6/24/20
Magenta Therapeutics Launches Proposed Public Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplant to more patients, . . .
Posted on 6/24/20
Life Image Announces a Partnership with RapidAI
BOSTON--(BUSINESS WIRE)--Life Image, the world’s largest global medical evidence and image exchange network specializing in curated diagnostic images for care delivery and research, announced today a . . .
Posted on 6/24/20
1upHealth Named a 'Cool Vendor in Healthcare Interoperability' by Gartner for its FHIR Platform
1upHealth was just named a 'Cool Vendor', in Gartner's Cool Vendors in Healthcare Interoperability, a publication spotlighting companies that have innovative approaches in electronic health data . . .
Posted on 6/24/20
La Jolla Pharmaceutical Company to Acquire Tetraphase Pharmaceuticals
La Jolla Pharmaceutical Company, which is dedicated to the development and commercialization of innovative therapies that improve outcomes
Posted on 6/24/20
Repertoire Immune Medicines Receives Funding
Repertoire Immune Medicines, a clinical-stage biotech company tooled to decode and deploy the immune system across multiple major diseases
Posted on 6/23/20
Repare Therapeutics Closes Upsized IPO
CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (Nasdaq: RPTX), a leading precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development . . .
Posted on 6/23/20
Forma Therapeutics Closes IPO
WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced the closing of its initial . . .
Posted on 6/23/20
WuXi NextCODE Restructures and Becomes Genuity Science
WuXi NextCODE today announced plans to restructure its operations and governance in order to best position the company for future growth, ground-breaking offerings for customers, and . . .
Posted on 6/23/20
States that Have the Fewest Coronavirus Restrictions – Updated WalletHub Study
With all states gradually reopening but monitoring for any spikes in COVID-19 cases that would impact their reopening plans, the personal-finance website WalletHub today released updated . . .
Posted on 6/23/20
Own Biogen For Long-Term Safety And Growth
SummaryBiogen is the neuroscience market leader and continues making investments to maintain that lead.Neurological disease treatments represent the largest unmet need in the medical industry with . . .
Posted on 6/22/20
Leap Therapeutics Closes Public Offering of Common Stock and Pre-Funded Warrants
Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the closing of a public offering of 20,250,000 shares of . . .
Posted on 6/22/20
Agenus and Betta Pharmaceuticals Enter Into a License Agreement for Balstilimab and Zalifrelimab in Greater China
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with an extensive pipeline of agents designed to activate immune response to cancers, announced today that it has . . .
Posted on 6/22/20
Minerva Biotechnologies Announces License Agreement with Memorial Sloan Kettering Cancer Center
WALTHAM, Mass.--(BUSINESS WIRE)--Minerva Biotechnologies (Minerva) today announced that it has licensed from Memorial Sloan Kettering Cancer Center (MSK) “1XX” technology for use with Minerva’s proprietary anti-MUC1* . . .
Posted on 6/22/20
CVS Health: An Amazon-Proof Business On Sale
CVS Health has transformed itself into a leading healthcare provider company.READ FULL ARTICLE HERE
Posted on 6/21/20
Constellation Pharmaceuticals Proposes Public Offering of Common Stock
CAMBRIDGE, Mass., (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc., (Nasdaq: CNST) a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today . . .
Posted on 6/21/20
Generation Bio Prices IPO
CAMBRIDGE, Mass., (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of gene therapy, today announced the pricing . . .
Posted on 6/21/20
Agios and Royalty Pharma Announce $255M Purchase Agreement for IDHIFA Royalty
CAMBRIDGE, Mass. and NEW YORK (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat cancer and rare . . .
Posted on 6/21/20
AVEO Closes Public Offering of Common Stock
BOSTON--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today announced the closing of its previously announced underwritten public offering of 9,725,000 shares of its common stock, which includes the . . .
Posted on 6/19/20
Repare Therapeutics Prices Upsized IPO
CAMBRIDGE, Mass. & MONTRÉAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (Nasdaq: RPTX), a leading precision oncology company enabled by our proprietary synthetic lethality approach to the discovery and development . . .
Posted on 6/19/20
Forma Therapeutics Prices IPO
WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today announced the pricing of its initial . . .
Posted on 6/19/20
Biogen Loses Patent Case Over Its Best-Selling Drug
Biogen's (NASDAQ:BIIB) Tecfidera is one of the world's best-selling multiple sclerosis drugs, and on Thursday, a judge in the Northern District of West Virginia ruled that . . .
Posted on 6/18/20
GNS Healthcare and Multiple Myeloma Research Foundation (MMRF) Announce a Five-Year Collaboration
GNS Healthcare and the Multiple Myeloma Research Foundation (MMRF) today announced a five-year partnership to leverage the longitudinal multi-modal patient registry data from the MMRF CoMMpass . . .
Posted on 6/18/20
Leap Therapeutics Announces Pricing of $45 Million of Common Stock
Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the pricing of an underwritten public offering of its common . . .
Boston
